Cole S Hudson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Cole S Hudson

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The Journal of Antimicrobial Chemotherapy|August 29, 2022

Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniaeVincent H Tam, Paul R Merlau, Cole S Hudson, et al.

Toxicology and Applied Pharmacology|September 6, 2025

Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicityCole S Hudson, James E Smith, Rongjin Sun, et al.

Antimicrobial Agents and Chemotherapy|July 8, 2025

Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicityCole S Hudson, James E Smith, Linh T Vuong, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The Journal of Antimicrobial Chemotherapy|August 29, 2022

Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniaeVincent H Tam, Paul R Merlau, Cole S Hudson, et al.

Toxicology and Applied Pharmacology|September 6, 2025

Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicityCole S Hudson, James E Smith, Rongjin Sun, et al.

Antimicrobial Agents and Chemotherapy|July 8, 2025

Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicityCole S Hudson, James E Smith, Linh T Vuong, et al.

Pageof 2